ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
52 hedge funds and large institutions have $3.26M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
52
Holding in Top 10
–
Calls
$4K
Puts
–
Top Buyers
| 1 | +$87.2K | |
| 2 | +$51.5K | |
| 3 | +$11K | |
| 4 |
Morgan Stanley
New York
|
+$10.9K |
| 5 |
BWP
Balboa Wealth Partners
Scottsdale,
Arizona
|
+$10.3K |
Top Sellers
| 1 | -$566K | |
| 2 | -$43.3K | |
| 3 | -$37K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$19.2K |
| 5 |
CWA
CM Wealth Advisors
Beachwood,
Ohio
|
-$16K |